4th Quarter - Report

RYAN MACKINNON VASAPOLI AND BERZOK, LLP for NOVO NORDISK

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Law Enforcement/Crime/Criminal Justice LAW

S. 1002 SAFE DOSES Act and H.R. 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)

LobbyistCovered position, as disclosed
MATTHEW BERZOK LD, Chief Counsel, LA Rep. Stupak & Deutsch
NICK KOLOVOS LA Rep. Anna Eshoo (D-California)
JEFF MACKINNON LD & LA Rep. Joe Barton (R-Texas)
JEFFERY C MORTIER Staff on Energy & Commerce Committee
THOMAS RYAN —
JOSEPH V VASAPOLI Min. Counsel, Energy&Comm, Special Asst. DOE

Contacted: Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS); SENATE; Executive Office of the President (EOP)

Bills named: H.R. 4223 (112th), S. 1002 (112th)

Trade (domestic/foreign) TRD

Trans-Pacific Partnership (TPP): biosimilar provisions

LobbyistCovered position, as disclosed
MATTHEW BERZOK LD, Chief Counsel, LA Rep. Stupak & Deutsch
NICK KOLOVOS LA Rep. Anna Eshoo (D-California)
JEFF MACKINNON LD & LA Rep. Joe Barton (R-Texas)
JEFFERY C MORTIER Staff on Energy & Commerce Committee
THOMAS RYAN —
JOSEPH V VASAPOLI Min. Counsel, Energy&Comm, Special Asst. DOE

Contacted: Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); Labor, Dept of (DOL); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE

Taxation/Internal Revenue Code TAX

H.R. 436- Protect Medical Innovation Act of 2011

LobbyistCovered position, as disclosed
MATTHEW BERZOK LD, Chief Counsel, LA Rep. Stupak & Deutsch
NICK KOLOVOS LA Rep. Anna Eshoo (D-California)
JEFF MACKINNON LD & LA Rep. Joe Barton (R-Texas)
JEFFERY C MORTIER Staff on Energy & Commerce Committee
THOMAS RYAN —
JOSEPH V VASAPOLI Min. Counsel, Energy&Comm, Special Asst. DOE

Contacted: Labor, Dept of (DOL); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); SENATE; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 436 (112th)

Health Issues HCR

P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: biosimilar provisions

LobbyistCovered position, as disclosed
MATTHEW BERZOK LD, Chief Counsel, LA Rep. Stupak & Deutsch
NICK KOLOVOS LA Rep. Anna Eshoo (D-California)
JEFF MACKINNON LD & LA Rep. Joe Barton (R-Texas)
JEFFERY C MORTIER Staff on Energy & Commerce Committee
THOMAS RYAN —
JOSEPH V VASAPOLI Min. Counsel, Energy&Comm, Special Asst. DOE

Contacted: Executive Office of the President (EOP); Labor, Dept of (DOL); Food & Drug Administration (FDA); SENATE; Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid MMM

P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 6548 Medicare Diabetes Prevention Act of 2012; S 3463 Medicare Diabetes Prevention Act of 2012; HR 2741 Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction)

LobbyistCovered position, as disclosed
MATTHEW BERZOK LD, Chief Counsel, LA Rep. Stupak & Deutsch
NICK KOLOVOS LA Rep. Anna Eshoo (D-California)
JEFF MACKINNON LD & LA Rep. Joe Barton (R-Texas)
JEFFERY C MORTIER Staff on Energy & Commerce Committee
THOMAS RYAN —
JOSEPH V VASAPOLI Min. Counsel, Energy&Comm, Special Asst. DOE

Contacted: Labor, Dept of (DOL); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 2741 (112th), H.R. 6548 (112th)

Budget/Appropriations BUD

S. 3295 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2013 (National Diabetes Prevention Program); HR 6482 The Preventative Health Savings Act of 2012 (modernizing cost estimates with respect to preventive health legislation (scoring)); National Diabetes Prevention Program

LobbyistCovered position, as disclosed
MATTHEW BERZOK LD, Chief Counsel, LA Rep. Stupak & Deutsch
NICK KOLOVOS LA Rep. Anna Eshoo (D-California)
JEFF MACKINNON LD & LA Rep. Joe Barton (R-Texas)
JEFFERY C MORTIER Staff on Energy & Commerce Committee
THOMAS RYAN —
JOSEPH V VASAPOLI Min. Counsel, Energy&Comm, Special Asst. DOE

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Labor, Dept of (DOL); SENATE; Executive Office of the President (EOP); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 3295 (112th), H.R. 6482 (112th)

Pharmacy PHA

P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions; S.3187 FDA Safety and Innovation Act (PDUFA V); H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B

LobbyistCovered position, as disclosed
MATTHEW BERZOK LD, Chief Counsel, LA Rep. Stupak & Deutsch
NICK KOLOVOS LA Rep. Anna Eshoo (D-California)
JEFF MACKINNON LD & LA Rep. Joe Barton (R-Texas)
JEFFERY C MORTIER Staff on Energy & Commerce Committee
THOMAS RYAN —
JOSEPH V VASAPOLI Min. Counsel, Energy&Comm, Special Asst. DOE

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE; Labor, Dept of (DOL); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP)

Bills named: H.R. 5973 (112th), H.R. 3026 (112th), S. 3187 (112th), H.R. 4274 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.